Inhibition of TNF and CD95(APO-1/Fas) ligand as a novel therapy for stroke
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2002
|
| In: |
Emirates medical journal
Year: 2002, Volume: 20, Pages: 9-11 |
| ISSN: | 0250-6882 |
| Online Access: |
|
| Author Notes: | Martin-Villalba, A. and Krammer, P.H. |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1750151448 | ||
| 003 | DE-627 | ||
| 005 | 20220819123955.0 | ||
| 007 | tu | ||
| 008 | 210302s2002 xx ||||| 00| ||eng c | ||
| 035 | |a (DE-627)1750151448 | ||
| 035 | |a (DE-599)KXP1750151448 | ||
| 035 | |a (OCoLC)1341396609 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Martín-Villalba, Ana |d 1971- |e VerfasserIn |0 (DE-588)12035988X |0 (DE-627)696601338 |0 (DE-576)292177690 |4 aut | |
| 245 | 1 | 0 | |a Inhibition of TNF and CD95(APO-1/Fas) ligand as a novel therapy for stroke |c Martin-Villalba, A. and Krammer, P.H. |
| 264 | 1 | |c 2002 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Krammer, Peter H. |d 1946- |e VerfasserIn |0 (DE-588)121766373 |0 (DE-627)081520255 |0 (DE-576)292873417 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Emirates medical journal |d Dubai : Assoc., 1980 |g 20(2002), Seite 9-11 |w (DE-627)220969809 |w (DE-600)1353854-8 |w (DE-576)9220969807 |x 0250-6882 |7 nnas |a Inhibition of TNF and CD95(APO-1/Fas) ligand as a novel therapy for stroke |
| 773 | 1 | 8 | |g volume:20 |g year:2002 |g pages:9-11 |g extent:3 |a Inhibition of TNF and CD95(APO-1/Fas) ligand as a novel therapy for stroke |
| 951 | |a AR | ||
| 992 | |a 20210302 | ||
| 993 | |a Article | ||
| 994 | |a 2002 | ||
| 998 | |g 121766373 |a Krammer, Peter H. |m 121766373:Krammer, Peter H. |d 50000 |e 50000PK121766373 |k 0/50000/ |p 2 |y j | ||
| 998 | |g 12035988X |a Martín-Villalba, Ana |m 12035988X:Martín-Villalba, Ana |d 50000 |e 50000PM12035988X |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1750151448 |e 3880202168 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"3 S."}],"type":{"bibl":"article-journal"},"language":["eng"],"relHost":[{"pubHistory":["1.1980 -"],"part":{"text":"20(2002), Seite 9-11","volume":"20","extent":"3","year":"2002","pages":"9-11"},"disp":"Inhibition of TNF and CD95(APO-1/Fas) ligand as a novel therapy for strokeEmirates medical journal","type":{"bibl":"periodical"},"language":["eng"],"recId":"220969809","origin":[{"publisherPlace":"Dubai","dateIssuedDisp":"1980-","dateIssuedKey":"1980","publisher":"Assoc."}],"title":[{"title":"Emirates medical journal","subtitle":"official publication of the Emirates Medical Association","title_sort":"Emirates medical journal"}],"id":{"issn":["0250-6882"],"zdb":["1353854-8"],"eki":["220969809"]}}],"recId":"1750151448","person":[{"display":"Martín-Villalba, Ana","roleDisplay":"VerfasserIn","role":"aut","family":"Martín-Villalba","given":"Ana"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Krammer, Peter H.","given":"Peter H.","family":"Krammer"}],"name":{"displayForm":["Martin-Villalba, A. and Krammer, P.H."]},"origin":[{"dateIssuedDisp":"2002","dateIssuedKey":"2002"}],"title":[{"title":"Inhibition of TNF and CD95(APO-1/Fas) ligand as a novel therapy for stroke","title_sort":"Inhibition of TNF and CD95(APO-1/Fas) ligand as a novel therapy for stroke"}],"id":{"eki":["1750151448"]}} | ||
| SRT | |a MARTINVILLINHIBITION2002 | ||